A multi-centre, randomized, double-blind, placebo-controlled clinical trial of the efficacy and safety of chloroquine phosphate, hydroxychloroquine sulphate and lopinavir/ritonavir for the treatment of COVID-19 in Lagos State: study protocol for a randomized controlled trial

Abstract Background The coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that was first identified in Wuhan, Hubei, China, in December 2019. It was recognized as a pandemic by the World Health Organization on 11 March 2020. Outbreak fo...

Description complète

Détails bibliographiques

Auteurs principaux:	A. Abayomi, A. Osibogun, O. Ezechi, K. Wright, B. Ola, O. Ojo, Y. Kuyinu, E. Zamba, H. Abdur-Razzaq, O. A. Erinoso, S. E. Anya
Format:	Artigo
Langue:	Inglês
Publié:	BMC 2021-12-01
Collection:	Trials
Sujets:	COVID-19 SARS-CoV-2 2019-nCoV Chloroquine Hydroxychloroquine Lopinavir/ritonavir
Accès en ligne:	https://doi.org/10.1186/s13063-021-05675-x
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!